Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

Sep. 9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million ...

MinJun Kim, the Robert C. Womack Endowed Chair Professor at SMU Lyle School of Engineering, and his research team have ...

Gene therapy may restore vision to children and adults robbed of their sight by a rare inherited condition called Leber ...

Penn gene therapy pioneer Dr. Jim Wilson said his decision to leave academia to become full-time CEO of two startups he ...

Of course, GC Therapeutics could also mean gene and cell therapeutics ... “These are the disease areas that really we believe ...

HighField Biopharmaceuticals’ new immuno-oncology drug molecule HF1K16 shows safe and signals efficacy in treating refractory metastatic cancers: Hanghou, China Wednesday, Septe ...

A new generation of automated technologies in cell and gene therapy manufacturing systems will help more people benefit according to research identifying high production cost as the main ...

Loss of normal p53 function has been associated with resistance to both chemotherapy and radiotherapy. Introduction of wild-type (wt) p53 by means of adenoviral vectors has been shown to inhibit ...

In a recent study, topical application of both naked and liposome-entrapped plasmid vectors ... This topical vaccine gene therapy depended on the presence of normal hair follicles, suggesting ...

Intravenous RNAi gene therapy using Trojan horse liposomes has ... Glutathione PEGylated liposomal doxorubicin (2B3–101) is in Phase I/II clinical trials in patients with brain cancer.

Drug–ligand conjugates and ligand-anchored carrier systems encapsulating drug/gene have been developed and well characterized for the purpose of targeted breast cancer therapy. Liposomes serve ...